

Repair Biotechnologies Information
Contact top employees from
Repair Biotechnologies
Summary
Repair Biotechnologies is a private company that has been in the industry for 7 years. The company currently specializes in the Biotechnology area. The position of the Co-Founder & CEO is occupied by - Reason. Its headquarters is located at Syracuse, New York, USA. The Repair Biotechnologies annual revenue is estimated at < 1M. Total funding of the company - $6.9M. To connect with Repair Biotechnologies employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
1-10 employees
DMA Code
Syracuse Metropolitan Area
Founded
2018
Operating Status
Independent Company
Contact Repair Biotechnologies
Organization Website
Social Links
Phone Number
1-315-299-2407
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
2009 | Privately Held | 25 - 100 | 5.6M | $197.7M | |
2017 | Privately Held | 25 - 100 | < 1M | $165M | |
2019 | - | 10-50 | - | $- | |
- | - | 10-50 | - | $- |
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at Repair Biotechnologies shows a diverse range of experience levels:
22% have been with the company for less than 1 year11% for 1–2 years33% for 3–4 years33% for 5–7 yearsContact top employees from
Repair Biotechnologies
Mourad Topors
Chief Scientific Officer
Iyan Warren
Scientist 2
Kufre Inyang
Scientist 3
Garrett Strough
Scientist III
Brendan Hickey
Scientist I
Karim Sahbani
Scientist
Similar Companies
FAQ
Repair Biotechnologies operates in the Biotechnology industries. More details can be found on the official website: repairbiotechnologies.com.
The headquarters of Repair Biotechnologies are located in Syracuse, United States.
The current CEO of Repair Biotechnologies is - Reason
You can contact Repair Biotechnologies by phone at 1-315-299-2407.
Repair Biotechnologies currently employs 1-10 people.
Repair Biotechnologies's revenue is approximately < 1M.
Well-known competitors of Repair Biotechnologies include Aura Biosciences, Tango Therapeutics, OCEAN BIOMEDICAL and Sagimet Biosciences.